NEK2 phosphorylation antagonizes the microtubule stabilizing activity of centrobin.

Biochem Biophys Res Commun

Department of Biological Sciences, Seoul National University, Seoul 151-747, Republic of Korea.

Published: February 2013

Centrobin was initially identified as a centrosome protein for centriole duplication. Centrobin is also detected outside the centrosome and involved in other cellular functions, such as spindle assembly. We previously reported that centrobin is a substrate of both NEK2 and PLK1, but it is not clear what functional properties of centrobin are regulated by two kinases. Here, we report that centrobin is involved in cell spreading, migration and microtubule stabilization in interphase cells. The NEK2-depleted cells looked spread with well-developed microtubule networks and migrated faster than the control cells. The microtubule stability in NEK2-depleted cells was higher than the control cells. However, the opposite was the case in centrobin-depleted cells. The opposite outcomes in NEK2- and centrobin-depleted cells suggest that NEK2 antagonizes biological functions of centrobin. We identified NEK2 phosphorylation sites within centrobin, which is distinct from the PLK1 phosphorylation sites. In fact, the phospho-resistant mutant of centrobin against NEK2 stabilized microtubule networks in vivo. Based on the results, we propose that NEK2 phosphorylation antagonizes the microtubule stabilizing activity of centrobin. Centrobin is a novel example that NEK2 and PLK1 independently phosphorylate a substrate and result in opposite outcomes in substrate function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2012.12.106DOI Listing

Publication Analysis

Top Keywords

nek2 phosphorylation
12
centrobin
11
phosphorylation antagonizes
8
antagonizes microtubule
8
microtubule stabilizing
8
stabilizing activity
8
activity centrobin
8
centrobin centrobin
8
nek2 plk1
8
nek2-depleted cells
8

Similar Publications

Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) plays a critical role in regulating the activity of Rho guanosine triphosphatases (GTPases). Phosphorylation of RhoGDI1 dynamically modulates the activation of Rho GTPases, influencing cell proliferation and migration. This study explored the involvement of Never In Mitosis A (NIMA)-related serine/threonine protein kinase 2 (NEK2) in phosphorylating RhoGDI1 and its implications in cancer cell behavior associated with tumor progression.

View Article and Find Full Text PDF

NEK2 (NIMA-related kinase 2) has recently gained attention for its potential role in osteoarthritis (OA) chondrocytes, however, its specific involvement remains unclear. This study aimed to investigate the role of NEK2 in OA progression and the underlying molecular mechanisms. Primary mouse knee chondrocytes were stimulated with IL-1β to establish an in vitro OA model, followed by the knockdown of NEK2 or ATF2.

View Article and Find Full Text PDF

Cisplatin-based concurrent chemoradiotherapy (CCRT) is the standard treatment for cervical patients with locally advanced disease. Despite the improved survival rates and prognosis observed in patients undergoing CCRT, over 30-40% do not achieve complete response and are at risk of locoregional recurrence. Targeting crucial molecules that confer resistance may improve the clinical outcomes of the treatment resistant patient cohort.

View Article and Find Full Text PDF

NEK2 promotes colorectal cancer progression by activating the TGF-β/Smad2 signaling pathway.

Transl Oncol

January 2025

Department of Clinical Laboratory, Beijing Jishuitan Hospital Guizhou Hospital, No. 206, Sixian Street, Baiyun District, Guiyang City, Guizhou Province, China. Electronic address:

Colorectal cancer (CRC) is a prevalent malignancy with poor patient survival, and NIMA-associated kinase 2 (NEK2) has been implicated in the pathogenesis and progression of various cancers, including CRC. This study aimed to investigate the impact of NEK2 on CRC cell functionality and its interaction with the TGF-β/Smad signaling pathway. NEK2 expression in CRC tissues and cell lines was assessed, and its association with patient survival was analyzed.

View Article and Find Full Text PDF

Comprehensive proteomics analysis reveals novel Nek2-regulated pathways and therapeutic targets in cancer.

Biochem Biophys Res Commun

November 2024

Koç University, Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey; Koç University, School of Medicine, Istanbul, Turkey. Electronic address:

Article Synopsis
  • Nek2 is a mitotic kinase often overexpressed in cancers, influencing cell cycle processes, proliferation, and drug resistance, making it a target for cancer therapy.
  • A global proteomics analysis identified 1815 proteins, with 358 showing significant changes related to Nek2 modulation in cancer cells.
  • The study found a strong link between Nek2 levels and two proteins, KIF20B and RRM1, suggesting they could be effective therapeutic targets in conjunction with Nek2 inhibitors for better cancer treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!